Targeting the FGF/FGFR axis and its co-alteration allies

BACKGROUND: We analyzed the FGF/FGFR and co-alteration cancer landscape, hypothesizing that combination therapy might be useful in the presence of co-drivers. MATERIALS AND METHODS: We describe FGF/FGFR-altered pathways, prognosis, and co-alterations [cBioPortal (N = 7574)] and therapeutic outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Uehara, Y., Ikeda, S., Kim, K.H., Lim, H.J., Adashek, J.J., Persha, H.E., Okamura, R., Lee, S., Sicklick, J.K., Kato, S., Kurzrock, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808461/
https://www.ncbi.nlm.nih.gov/pubmed/36455506
http://dx.doi.org/10.1016/j.esmoop.2022.100647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808461/
https://www.ncbi.nlm.nih.gov/pubmed/36455506
http://dx.doi.org/10.1016/j.esmoop.2022.100647

Ejemplares similares